Controlled Substances Regulations (SOR/2025-242)

Marginal note:General condition

• The following provision is not in force.

  131 (1) A practitioner may administer a controlled substance, other than a restricted drug, to an individual or animal if the practitioner first issues a written prescription.

• The following provision is not in force.

  Marginal note:Restricted drugs

  (2) A practitioner may administer a restricted drug to an individual if

  • The following provision is not in force.

    (a) the practitioner is treating the individual in their professional capacity; and

  • The following provision is not in force.

    (b) the practitioner has received a copy of the letter of authorization in which they are named.

Marginal note:Emergency supply

• The following provision is not in force.

  132 (1) A practitioner of medicine who is responsible for an emergency supply must ensure that

  • The following provision is not in force.

    (a) the emergency supply does not contain a restricted drug; and

  • The following provision is not in force.

    (b) they have an agent or mandatary who is present at the place where the emergency supply is stored and who will, under their direction, administer the controlled substance under their control.

• The following provision is not in force.

  Marginal note:Administration — conditions

  (2) In an emergency, the agent or mandatary of the practitioner of medicine may administer a controlled substance from the emergency supply to an individual if

  • The following provision is not in force.

    (a) the practitioner of medicine has directed the agent or mandatary to administer the controlled substance; or

  • The following provision is not in force.

    (b) the agent or mandatary follows written directives provided by the practitioner of medicine with respect to the administration of the controlled substance.

Marginal note:Receipt of substance from individual

133 A practitioner who receives a controlled substance from an individual for the purposes of destruction must keep the substance in a collection container that is in a secure location to which only persons whom the practitioner has authorized have access and that is marked in a manner that is sufficient to identify the container.

Marginal note:Authorized access

• The following provision is not in force.

  134 (1) Subject to subsection (2), a practitioner who stores a controlled substance must ensure that

  • The following provision is not in force.

    (a) they store the controlled substance in a secure location in the place where they practise; and

  • The following provision is not in force.

    (b) only persons whom the practitioner has authorized have access to that secure location.

• The following provision is not in force.

  Marginal note:Emergency supply

  (2) A practitioner of medicine who stores an emergency supply need only ensure that

  • The following provision is not in force.

    (a) they take all reasonable measures to ensure that the place of storage is secure; and

  • The following provision is not in force.

    (b) only the practitioner of medicine and their agent or mandatary have access to that secure place.

Marginal note:Authorization

135 A practitioner may deliver, send or transport a controlled substance.

Marginal note:Requirements during transportation

136 A practitioner who delivers, sends or transports a controlled substance to another person may only do so if they

• The following provision is not in force.

  (a) ensure that, if the controlled substance is being delivered, sent or transported to a licensed dealer specialized in destruction, the substance is placed in a container that is sealed in such a manner that it cannot be opened without breaking the seal and is marked in a manner that is sufficient to identify the container;

• The following provision is not in force.

  (b) take all reasonable measures to ensure the security of the controlled substance while it is being delivered, sent or transported; and

• The following provision is not in force.

  (c) use a method of delivery, sending or transportation that ensures the tracking of the controlled substance until the consignee receives it.

Marginal note:Protective measures

137 A practitioner must take all reasonable measures to ensure the security of any controlled substance in their possession.

Marginal note:Loss or theft — agent or mandatary

• The following provision is not in force.

  138 (1) If an agent or mandatary of a practitioner becomes aware of a loss or theft of a controlled substance, the agent or mandatary must notify the practitioner immediately.

• The following provision is not in force.

  Marginal note:Written report

  (2) If a practitioner becomes aware of a loss or theft of a controlled substance, or is notified by an agent or mandatary of such a loss or theft, the practitioner must provide a written report to the Minister within 10 days after the day on which they become aware of the loss or theft or are notified.

• The following provision is not in force.

  Marginal note:Partial protection against self-incrimination

  (3) The report, or any evidence derived from it, is not to be used or received to incriminate the practitioner or their agent or mandatary in any criminal proceeding against them other than a prosecution under section 132, 136 or 137 of the Criminal Code.

Marginal note:Conditions

• The following provision is not in force.

  139 (1) The destruction of a controlled substance may be carried out by a practitioner only if the following conditions are met:

  • The following provision is not in force.

    (a) the destruction is witnessed by another person among the following:

    • (i) a pharmacist, pharmacy technician or intern,

    • (ii) a practitioner, or

    • (iii) any other health professional;

  • The following provision is not in force.

    (b) the destruction is carried out in accordance with a method that complies with all federal, provincial and municipal environmental protection legislation applicable to the place of destruction; and

  • The following provision is not in force.

    (c) immediately following the destruction, the person who carried out the destruction and the witness sign and date a joint declaration attesting that the controlled substance was destroyed, to which each signatory must add their name in printed letters.

• The following provision is not in force.

  Marginal note:Exception — open ampule

  (2) A practitioner may, without a witness, destroy the remainder of a controlled substance that is contained in an open ampule and that will not be administered.

• The following provision is not in force.

  Marginal note:Substance returned by individual

  (3) A practitioner must, if the destruction of a controlled substance previously returned by an individual for the purposes of destruction was not carried out, sell or provide the substance to a licensed dealer specialized in destruction.

Marginal note:Scope

140 The requirements set out in sections 141 to 152 apply to a practitioner with respect to the following controlled substances:

• The following provision is not in force.

  (a) if the practitioner is not practising in a hospital, a narcotic, controlled drug or targeted substance; and

• The following provision is not in force.

  (b) a restricted drug.

Marginal note:Substances received

141 A practitioner who receives a controlled substance, other than one that has been previously returned by an individual for the purposes of destruction, must record the following information:

• The following provision is not in force.

  (a) with respect to the person from whom the controlled substance is received, their name and, if applicable, title, as well as their municipal address;

• The following provision is not in force.

  (b) the date of receipt;

• The following provision is not in force.

  (c) in the case of a controlled substance set out in any of Schedules 1 to 4, its name, form and quantity; and

• The following provision is not in force.

  (d) in the case of a finished product,

  • (i) its name or, if applicable, brand name,

  • (ii) its form, strength and quantity, and

  • (iii) its drug identification number, if any.

Marginal note:Substances sold — persons other than individuals

142 A practitioner who sells or provides a controlled substance to a person, other than an individual referred to in section 143, must record

• The following provision is not in force.

  (a) the practitioner’s name;

• The following provision is not in force.

  (b) with respect to the person, their name and, if applicable, title, as well as their municipal address;

• The following provision is not in force.

  (c) the date of the sale or provision;

• The following provision is not in force.

  (d) in the case of a controlled substance set out in any of Schedules 1 to 4, its name, form and quantity; and

• The following provision is not in force.

  (e) in the case of a finished product,

  • (i) subject to subparagraph (iv), its name or, if applicable, brand name,

  • (ii) subject to subparagraph (iv), its form, strength and quantity,

  • (iii) subject to subparagraph (iv), its drug identification number, if any, and

  • (iv) if the finished product has been previously returned by an individual for the purposes of destruction, only the identifier marked on the collection container of the finished product and the number of collection containers.

Marginal note:Substances prescribed, administered or sold — individuals

• The following provision is not in force.

  143 (1) A practitioner who conducts the following activities must record the information set out in subsection (2):

  • The following provision is not in force.

    (a) prescribe or administer a controlled substance to an individual or an animal; or

  • The following provision is not in force.

    (b) sell or provide a controlled substance to an individual for their own use, for the use of another individual or for an animal.

• The following provision is not in force.

  Marginal note:Information

  (2) The information that must be recorded is the following:

  • The following provision is not in force.

    (a) the practitioner’s name;

  • The following provision is not in force.

    (b) the name of the individual who is named in the prescription or who is responsible for the animal identified in the prescription and, if applicable, the name of the animal;

  • The following provision is not in force.

    (c) in the case of an administration, sale or provision of a restricted drug to an individual, their name;

  • The following provision is not in force.

    (d) the date of the prescription, administration, sale or provision;

  • The following provision is not in force.

    (e) in the case of a controlled substance set out in any of Schedules 1 to 4, its name, form and quantity;

  • The following provision is not in force.

    (f) in the case of a finished product,

    • (i) its name or, if applicable, brand name,

    • (ii) its form, strength and quantity,

    • (iii) its drug identification number, if any, and

    • (iv) if the finished product that is sold or provided, other than one containing a restricted drug, is intended for administration by the individual to themselves or the animal, and if the dose exceeds the following, a statement to that effect:

      • (A) in the case of a finished product containing a controlled drug or narcotic, three times the maximum daily dosage recommended by the producer of the product or, if the producer has not recommended a maximum daily dosage, three times the generally recognized maximum daily therapeutic dosage for that product, or

      • (B) in the case of a finished product containing a targeted substance, five times the usual daily dose for the product.

Marginal note:Emergency supply

144 A practitioner of medicine who is responsible for an emergency supply must record the following information:

• The following provision is not in force.

  (a) the name of their agent or mandatary administering the controlled substance;

• The following provision is not in force.

  (b) the place where the emergency supply is stored;

• The following provision is not in force.

  (c) in the case of a controlled substance set out in any of Schedules 1 to 3, its name, form and quantity;

• The following provision is not in force.

  (d) in the case of a finished product,

  • (i) its name or, if applicable, brand name,

  • (ii) its form, strength and quantity, and

  • (iii) its drug identification number, if any;

• The following provision is not in force.

  (e) the date of all activities related to that emergency supply; and

• The following provision is not in force.

  (f) if a controlled substance was administered to an individual, the following information:

  • (i) the name of the individual,

  • (ii) in the case of a controlled substance set out in any of Schedules 1 to 3, its name, form and quantity, and

  • (iii) in the case of a finished product,

    • (A) its name or, if applicable, brand name,

    • (B) its form, strength and quantity, and

    • (C) its drug identification number, if any.